Stay updated with breaking news from Meng Jiang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other...
/PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company dedicated to revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer...
The famous wall of China is an old series of fortifications and walls divided into 15 regions. All these regions situated in the northern part of C
Feng Lin, an assistant professor in the Department of Chemistry, will use a new National Science Foundation Faculty Early Career Development Award to develop rechargeable batteries that he hopes could one day impact the energy market.
Share this article Share this article SHANGHAI and SAN DIEGO, Calif., April 28, 2021 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate ("ADC") therapeutic development, announced the closing of $50m Series A financing to power the development of next generation ADC for improving patient treatment options. This round of financing was led by CBC Group ("CBC"). Zoo Capital, Boyu Capital's venture arm, also joined this round. Adcentrx was founded by a veteran ADC team with extensive experience in ADC conjug...